AlphAIalphai — Financial news for AI agents
Finviz - Stock ScreenerFEB 243 min read$MMSI

Merit Medical Systems (NASDAQ:MMSI) Exceeds Q4 CY2025 Expectations

Merit Medical Systems (NASDAQ:MMSI) announced better-than-expected revenue for Q4 CY2025, with sales up 10.9% year-on-year to $393.9 million, surpassing analyst estimates. Both the full-year revenue guidance and adjusted EBITDA also beat expectations, although non-GAAP profit for the quarter slightly missed consensus estimates. The company showed strong operating margin improvement and impressive long-term EPS growth, despite a minor miss on quarterly adjusted EPS.

Original reporting
Finviz - Stock Screener · Adam Hejl
Published Feb 24, 2026, 9:55 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Feb 24, 2026, 11:30 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Merit Medical Systems (NASDAQ:MMSI) Exceeds Q4 CY2025 Expectations — source image
Source · Finviz - Stock Screener
Decision brief

The 30-second read

$MMSIBullishMed
01

Why it matters

Positive earnings may lead to increased investor confidence, potentially boosting stock prices and sector sentiment.

02

Market read

The company's earnings report is a significant event for investors in the healthcare and medical device sectors, with potential ripple effects across related stocks.

03

What to watch

Potential supply chain disruptions or macroeconomic headwinds could temper gains; consider broader economic indicators.

Timing: Immediate to short-term

Background

Merit Medical Systems' strong Q4 CY2025 earnings reflect effective operational management and market demand.

Company-level read

Ticker impact

$MMSIBullishHigh confidence
Context

Primary focus due to strong quarterly earnings and positive sentiment.

Expected impact

Moderate upward movement expected in the short term, with potential for sustained growth if earnings momentum continues.

Evidence & confidence

Strong revenue growth, improved operating margins, and positive analyst sentiment support an optimistic outlook; however, minor EPS miss introduces some caution.

Market effects

Sector

Positive sentiment for the medical devices and life sciences sectors, indicating industry-wide resilience.

Regional

Potential uplift in North American markets where these companies are primarily listed.

Global

Limited; primarily regional impact with some influence on global healthcare equipment markets.

Counterpoint

What could challenge this read

The earnings beat may be already priced in; caution is advised as non-GAAP profit slightly missed consensus.

Key entities

  • Company
    Merit Medical Systems

    A medical device manufacturer specializing in minimally invasive products.

  • Author
    Adam Hejl

    Journalist reporting on earnings.

Read at source← All news

Related articles

AUG 8
$MMSIMedAI 8/10

Merit Medical (MMSI) Q2 2026 Earnings Call Transcript

Merit Medical Systems (MMSI) reported Q2 2026 revenue of $418.8 million, up 10% GAAP, and non-GAAP EPS of $1.19. Non-GAAP operating margin was 22.6% and free cash flow $51.9 million. The company raised 2026 revenue guidance to $1.631B-$1.643B and non-GAAP EPS to $4.25-$4.35, and guided Q3 revenue to $408M-$413M.

fool.com6 min
JUL 31
$MMSIMedAI 8/10

These Analysts Increase Their Forecasts On Merit Medical Systems After Strong Q2 Results - Merit Medical

Merit Medical Systems Inc (NASDAQ:MMSI) posted better-than-expected earnings for the second quarter on Thursday. The company posted adjusted EPS of $1.19, beating market estimates of 96 cents per share. The company’s sales came in at $418.843 million versus expectations of $405.268 million. Merit Medical Systems raised its FY2026 adjusted EPS guidance from $4.01-$4.15 to $4.25-$4.35 and increased its sales forecast from $1.612 billion-$1.634 billion to $1.631 billion-$1.643 billion.

benzinga.com3 min
JUL 30
$MMSIMedAI 8/10

Merit Medical Systems (NASDAQ:MMSI) Reports Bullish Q2 CY2026, Stock Soars

Medical device company Merit Medical Systems (NASDAQ: MMSI) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 9.5% year on year to $418.8 million. The company’s full-year revenue guidance of $1.64 billion at the midpoint came in 1.1% above analysts’ estimates. Its non-GAAP profit of $1.19 per share was 24% above analysts’ consensus estimates. Is now the time to buy Merit Medical Systems? Find out by accessing our full research report, it’s free.

financialcontent.com4 min
JUL 30
$MMSIHigh

MERIT MEDICAL SYSTEMS INC (MMSI): Results of Operations and Financial Condition

MERIT MEDICAL SYSTEMS INC (MMSI) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 mmsi-20260730xex99d1.htm EX-99.1 Exhibit 99.1 ​ ​ ​ ​ ​ ​ ​ ​ Contacts: ​ ​ ​ ​ PR/Media Inquiries: Sarah Comstock Merit Medical Investor Inquiries: Mike Piccinino, CFA, IRC ICR Healthcare ​ ​ +1-801-432-2864 +1-443-213-0509 ​ ​ sarah.comstock@merit.com mike.piccinino@i

SEC EDGAR 8-K6 min
AUG 8
$SUNEMedAI 8/10

Pentagon to invest $400m in Australian rare earth mine

Sunrise Energy Metals said the US Pentagon will provide a conditional $400 million loan commitment to develop Syerston, a proposed scandium mine in Fifield, NSW. The project targets Western supply of scandium used in defence and other sectors amid China’s export restrictions. Sunrise also said it has a deal with Lockheed Martin for 25% of output for five years.

bssnews.net4 min